These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22710906)

  • 21. Molecular Signatures of HIV-1 Envelope Associated with HIV-Associated Neurocognitive Disorders.
    Evering TH
    Curr HIV/AIDS Rep; 2018 Feb; 15(1):72-83. PubMed ID: 29460224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and treatment of HIV-associated neurocognitive disorders.
    Ferrando SJ
    New Dir Ment Health Serv; 2000; (87):25-35. PubMed ID: 11031798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurologic complications of HIV infection in children.
    Civitello LA
    Pediatr Neurosurg; 1991-1992; 17(2):104-12. PubMed ID: 1815729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection. Neuroradiological, neurophysiological, neuroimmunological, and virological correlates.
    Goodkin K; Wilkie FL; Concha M; Asthana D; Shapshak P; Douyon R; Fujimura RK; LoPiccolo C
    Neuroimaging Clin N Am; 1997 Aug; 7(3):561-79. PubMed ID: 9376968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HIV-1 associated encephalopathy and myelopathy].
    Eggers C
    Nervenarzt; 2000 Aug; 71(8):677-84. PubMed ID: 10996920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [HIV 1-associated neurocognitive disorder: current epidemiology, pathogenesis, diagnosis and management].
    Eggers C;
    Nervenarzt; 2014 Oct; 85(10):1280-90. PubMed ID: 25292163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CROI 2014: Neurologic complications of HIV infection.
    Spudich SS
    Top Antivir Med; 2014 May; 22(2):594-601. PubMed ID: 24901885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV infection of the central nervous system: clinical features and neuropathogenesis.
    Boissé L; Gill MJ; Power C
    Neurol Clin; 2008 Aug; 26(3):799-819, x. PubMed ID: 18657727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.
    Chan P; Brew BJ
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):317-24. PubMed ID: 24966139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebrospinal fluid inhibitory quotients of antiretroviral drugs in HIV-infected patients are associated with compartmental viral control.
    Calcagno A; Simiele M; Alberione MC; Bracchi M; Marinaro L; Ecclesia S; Di Perri G; D'Avolio A; Bonora S
    Clin Infect Dis; 2015 Jan; 60(2):311-7. PubMed ID: 25281609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India.
    Ghate M; Mehendale S; Meyer R; Umlauf A; Deutsch R; Kamat R; Thakar M; Risbud A; Kulkarni S; Sakamoto M; Alexander T; Franklin D; Letendre S; Heaton RK; Grant I; Marcotte TD
    J Neurovirol; 2015 Aug; 21(4):391-8. PubMed ID: 25750072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND).
    Zayyad Z; Spudich S
    Curr HIV/AIDS Rep; 2015 Mar; 12(1):16-24. PubMed ID: 25604237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 infection and cognitive impairment in minority groups.
    Selnes OA; Concha M; Palenicek JG
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):350-2. PubMed ID: 1498591
    [No Abstract]   [Full Text] [Related]  

  • 34. Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Wright EJ
    Curr Opin HIV AIDS; 2009 Sep; 4(5):447-52. PubMed ID: 20048710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of HIV in the CNS: effects of antiretroviral therapy and the promise of non-antiretroviral therapeutics.
    Peluso MJ; Spudich S
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):353-62. PubMed ID: 25063356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human immunodeficiency virus type 1 infection of the brain.
    Atwood WJ; Berger JR; Kaderman R; Tornatore CS; Major EO
    Clin Microbiol Rev; 1993 Oct; 6(4):339-66. PubMed ID: 8269391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating HIV Infection in the Central Nervous System.
    Calcagno A; Di Perri G; Bonora S
    Drugs; 2017 Feb; 77(2):145-157. PubMed ID: 28070871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective strategies for HIV-1 associated dementia.
    Dou H; Kingsley JD; Mosley RL; Gelbard HA; Gendelman HE
    Neurotox Res; 2004; 6(7-8):503-21. PubMed ID: 15639783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-associated neurocognitive disorder.
    Clifford DB; Ances BM
    Lancet Infect Dis; 2013 Nov; 13(11):976-86. PubMed ID: 24156898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.
    Rubin LH; Sundermann EE; Moore DJ
    J Neurovirol; 2019 Oct; 25(5):661-672. PubMed ID: 30671777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.